AGER and neoplasm: Regarding tumor angiogenesis, inhibiting the HMGB1/RAGE axis leads to a decrease in the expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR2, thereby inhibiting tumor angiogenesis.